1045 related articles for article (PubMed ID: 28445146)
1. Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity.
Koleini N; Kardami E
Oncotarget; 2017 Jul; 8(28):46663-46680. PubMed ID: 28445146
[TBL] [Abstract][Full Text] [Related]
2. Autophagic dysregulation in doxorubicin cardiomyopathy.
Bartlett JJ; Trivedi PC; Pulinilkunnil T
J Mol Cell Cardiol; 2017 Mar; 104():1-8. PubMed ID: 28108310
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor II receptor-α is a novel stress-inducible contributor to cardiac damage underpinning doxorubicin-induced oxidative stress and perturbed mitochondrial autophagy.
Pandey S; Kuo WW; Shen CY; Yeh YL; Ho TJ; Chen RJ; Chang RL; Pai PY; Viswanadha VP; Huang CY; Huang CY
Am J Physiol Cell Physiol; 2019 Aug; 317(2):C235-C243. PubMed ID: 31116582
[TBL] [Abstract][Full Text] [Related]
4. Mitophagy inhibitor liensinine suppresses doxorubicin-induced cardiotoxicity through inhibition of Drp1-mediated maladaptive mitochondrial fission.
Liang X; Wang S; Wang L; Ceylan AF; Ren J; Zhang Y
Pharmacol Res; 2020 Jul; 157():104846. PubMed ID: 32339784
[TBL] [Abstract][Full Text] [Related]
5. Evidences for the mechanism of Shenmai injection antagonizing doxorubicin-induced cardiotoxicity.
Wu YP; Zhang S; Xin YF; Gu LQ; Xu XZ; Zhang CD; You ZQ
Phytomedicine; 2021 Jul; 88():153597. PubMed ID: 34111614
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial Sirtuins and Doxorubicin-induced Cardiotoxicity.
He L; Liu F; Li J
Cardiovasc Toxicol; 2021 Mar; 21(3):179-191. PubMed ID: 33438065
[TBL] [Abstract][Full Text] [Related]
7. Doxorubicin-induced cardiomyocyte death is mediated by unchecked mitochondrial fission and mitophagy.
Catanzaro MP; Weiner A; Kaminaris A; Li C; Cai F; Zhao F; Kobayashi S; Kobayashi T; Huang Y; Sesaki H; Liang Q
FASEB J; 2019 Oct; 33(10):11096-11108. PubMed ID: 31291545
[TBL] [Abstract][Full Text] [Related]
8. Dosing depending on SIRT3 activity attenuates doxorubicin-induced cardiotoxicity via elevated tolerance against mitochondrial dysfunction and oxidative stress.
Yang N; Ma H; Jiang Z; Niu L; Zhang X; Liu Y; Wang Y; Cheng S; Deng Y; Qi H; Wang Z
Biochem Biophys Res Commun; 2019 Sep; 517(1):111-117. PubMed ID: 31303273
[TBL] [Abstract][Full Text] [Related]
9. The Cardioprotective Effect of Metformin in Doxorubicin-Induced Cardiotoxicity: The Role of Autophagy.
Zilinyi R; Czompa A; Czegledi A; Gajtko A; Pituk D; Lekli I; Tosaki A
Molecules; 2018 May; 23(5):. PubMed ID: 29762537
[TBL] [Abstract][Full Text] [Related]
10. The role of autophagy in doxorubicin-induced cardiotoxicity.
Dirks-Naylor AJ
Life Sci; 2013 Dec; 93(24):913-6. PubMed ID: 24404586
[TBL] [Abstract][Full Text] [Related]
11. Pathways of cardiac toxicity: comparison between chemotherapeutic drugs doxorubicin and mitoxantrone.
Damiani RM; Moura DJ; Viau CM; Caceres RA; Henriques JAP; Saffi J
Arch Toxicol; 2016 Sep; 90(9):2063-2076. PubMed ID: 27342245
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol-induced autophagy promotes survival and attenuates doxorubicin-induced cardiotoxicity.
Gu J; Hu W; Song ZP; Chen YG; Zhang DD; Wang CQ
Int Immunopharmacol; 2016 Mar; 32():1-7. PubMed ID: 26774212
[TBL] [Abstract][Full Text] [Related]
13. Exercise and Doxorubicin Treatment Modulate Cardiac Mitochondrial Quality Control Signaling.
Marques-Aleixo I; Santos-Alves E; Torrella JR; Oliveira PJ; Magalhães J; Ascensão A
Cardiovasc Toxicol; 2018 Feb; 18(1):43-55. PubMed ID: 28536949
[TBL] [Abstract][Full Text] [Related]
14. Phosphoinositide 3-Kinase Gamma Inhibition Protects From Anthracycline Cardiotoxicity and Reduces Tumor Growth.
Li M; Sala V; De Santis MC; Cimino J; Cappello P; Pianca N; Di Bona A; Margaria JP; Martini M; Lazzarini E; Pirozzi F; Rossi L; Franco I; Bornbaum J; Heger J; Rohrbach S; Perino A; Tocchetti CG; Lima BHF; Teixeira MM; Porporato PE; Schulz R; Angelini A; Sandri M; Ameri P; Sciarretta S; Lima-Júnior RCP; Mongillo M; Zaglia T; Morello F; Novelli F; Hirsch E; Ghigo A
Circulation; 2018 Aug; 138(7):696-711. PubMed ID: 29348263
[TBL] [Abstract][Full Text] [Related]
15. SESN2 protects against doxorubicin-induced cardiomyopathy via rescuing mitophagy and improving mitochondrial function.
Wang P; Wang L; Lu J; Hu Y; Wang Q; Li Z; Cai S; Liang L; Guo K; Xie J; Wang J; Lan R; Shen J; Liu P
J Mol Cell Cardiol; 2019 Aug; 133():125-137. PubMed ID: 31199952
[TBL] [Abstract][Full Text] [Related]
16. Nicotinamide riboside promotes autolysosome clearance in preventing doxorubicin-induced cardiotoxicity.
Zheng D; Zhang Y; Zheng M; Cao T; Wang G; Zhang L; Ni R; Brockman J; Zhong H; Fan GC; Peng T
Clin Sci (Lond); 2019 Jul; 133(13):1505-1521. PubMed ID: 31266854
[TBL] [Abstract][Full Text] [Related]
17. Doxorubicin triggers bioenergetic failure and p53 activation in mouse stem cell-derived cardiomyocytes.
Cunha-Oliveira T; Ferreira LL; Coelho AR; Deus CM; Oliveira PJ
Toxicol Appl Pharmacol; 2018 Jun; 348():1-13. PubMed ID: 29653124
[TBL] [Abstract][Full Text] [Related]
18. Everolimus prevents doxorubicin-induced apoptosis in H9c2 cardiomyocytes but not in MCF-7 cancer cells: Cardioprotective roles of autophagy, mitophagy, and AKT.
Kanno SI; Hara A
Toxicol In Vitro; 2023 Dec; 93():105698. PubMed ID: 37739323
[TBL] [Abstract][Full Text] [Related]
19. Protease-activated receptor 1 activation enhances doxorubicin-induced cardiotoxicity.
Antoniak S; Tatsumi K; Schmedes CM; Grover SP; Pawlinski R; Mackman N
J Mol Cell Cardiol; 2018 Sep; 122():80-87. PubMed ID: 30098988
[TBL] [Abstract][Full Text] [Related]
20. Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management.
Rawat PS; Jaiswal A; Khurana A; Bhatti JS; Navik U
Biomed Pharmacother; 2021 Jul; 139():111708. PubMed ID: 34243633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
